Trends in Cardiovascular Medicine

Papers
(The TQCC of Trends in Cardiovascular Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID-19 – A vascular disease244
Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention183
COVID-19 and thrombosis: From bench to bedside150
How useful is the smartwatch ECG?140
COVID-19 infection and cardiac arrhythmias87
Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference78
CardioVerse: The cardiovascular medicine in the era of Metaverse76
Myocardial ischemia-reperfusion injury and the influence of inflammation76
Update on acute myocarditis63
Multisystem inflammatory syndrome in children: Is there a linkage to Kawasaki disease?62
Marital status and outcomes in patients with cardiovascular disease58
Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?58
Mechanisms of mitral annular calcification58
Coronary heart disease risk: Low-density lipoprotein and beyond53
US trends in premature heart disease mortality over the past 50 years: Where do we go from here?50
Coffee and tea on cardiovascular disease (CVD) prevention49
Green environments and cardiovascular health48
Lung function and cardiovascular disease: A link48
Evaluating and managing bradycardia47
Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model47
Current understanding of fibrosis in genetic cardiomyopathies45
The role of the autonomic nervous system in cardiac arrhythmias: The neuro-cardiac axis, more foe than friend?43
US Physical Activity Guidelines: Current state, impact and future directions42
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic41
Viral myocarditis: 1917–2020: From the Influenza A to the COVID-19 pandemics41
Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels41
Detection of periodontal microorganisms in coronary atheromatous plaque specimens of myocardial infarction patients: A systematic review and meta-analysis37
Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies35
Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature35
COVID-19 and the brain33
Cardiovascular complications of sickle cell disease32
Artificial intelligence in cardiology32
Implications for the role of lipopolysaccharide in the development of atherosclerosis31
Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-1931
Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination31
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis31
Cardiovascular manifestations of myotonic dystrophy31
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment30
Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device28
The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia28
Semaglutide for the treatment of obesity28
Update in aortic dissection28
Depression and anxiety following acute myocardial infarction in women27
Flow-mediated vasodilation through mechanosensitive G protein-coupled receptors in endothelial cells26
Atrial fibrillation and stroke: A review and new insights24
Hype or hope: Vagus nerve stimulation against acute myocardial ischemia-reperfusion injury24
Modulation of microRNAs by aspirin in cardiovascular disease23
Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 202122
Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates21
Role of inflammatory cytokines in genesis and treatment of atherosclerosis21
Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention20
Premature atherosclerotic peripheral artery disease: An underrecognized and undertreated disorder with a rising global prevalence20
The role of inflammation in stress cardiomyopathy20
Pulmonary hypertension in aortic valve stenosis20
Congenital heart block: Pace earlier (Childhood) than later (Adulthood)19
The impact of influenza vaccination in patients with cardiovascular disease: An overview of systematic reviews19
Spontaneous coronary artery dissection: Overview of pathophysiology18
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases18
Mortality in atrial fibrillation. Is it changing?18
Importance of resting heart rate17
Migraine headache: Is it only a neurological disorder? Links between migraine and cardiovascular disorders17
Advances and challenges in pursuing biomarkers for obstructive sleep apnea: Implications for the cardiovascular risk17
Adverse effects of right ventricular pacing on cardiac function: prevalence, prevention and treatment with physiologic pacing16
Magnetic resonance imaging safety in patients with cardiac implantable electronic devices16
Clinical application of results of the ISCHEMIA trial15
Pulsed field catheter ablation in atrial fibrillation15
Primary aldosteronism15
Pulmonary artery denervation for pulmonary arterial hypertension14
Men are from mars, women are from venus: Factors responsible for gender differences in outcomes after surgical and trans-catheter aortic valve replacement14
Zika & heart: A systematic review14
Infective endocarditis in intravenous drug users14
Wearable cardioverter-defibrillators: A review of evidence and indications13
Effects of music on the cardiovascular system13
Diagnostic approach for coronary microvascular dysfunction in patients with chest pain and no obstructive coronary artery disease.13
Radiofrequency catheter ablation of atrial fibrillation: A review of techniques13
Artificial Intelligence and Transcatheter Interventions for Structural Heart Disease: A glance at the (near) future12
The proarrhythmic conundrum of alcohol intake12
Small abdominal aortic aneurysms: Has anything changed so far?12
Arrhythmogenic foods – A growing medical problem12
Non-invasive ablation of arrhythmias with stereotactic ablative radiotherapy12
Prediction and management of CAD risk based on genetic stratification12
MEF2 in cardiac hypertrophy in response to hypertension12
Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction12
Experimental limitations of extracellular vesicle-based therapies for the treatment of myocardial infarction12
Chagas’ cardiomyopathy and Lyme carditis: Lessons learned from two infectious diseases affecting the heart11
The subcutaneous implantable cardioverter defibrillator in 2019 and beyond11
Editorial commentary: Scanning for threats and natural environments giving our reptilian brains a break11
Cardiovascular pathophysiology from the cardioneural perspective and its clinical applications10
Editorial commentary: Recurrent pericarditis in the era of interleukin-1 inhibition10
Lipoprotein(a): Expanding our knowledge of aortic valve narrowing10
Adverse effects of air pollution‐derived fine particulate matter on cardiovascular homeostasis and disease10
Electrocardiographic features and rhythm disorders in cardiac amyloidosis10
The relationship between atrial fibrillation and coronary artery disease: Understanding common denominators10
Body mass and atrial fibrillation risk: Status of the epidemiology concerning the influence of fat versus lean body mass10
The use of smartwatch electrocardiogram beyond arrhythmia detection10
Successfully implemented artificial intelligence and machine learning applications in cardiology: State-of-the-art review10
Cardiac regenerative therapy: Many paths to repair9
Stroke prevention in atrial fibrillation9
Echocardiographic assessment of primary microvascular angina and primary coronary microvascular dysfunction9
Colchicine for the treatment of coronary artery disease9
Most important advances in preventive cardiology during this past decade: Viewpoint from the American Society for Preventive Cardiology9
Electromagnetic field therapy in cardiovascular diseases: A review of patents, clinically effective devices, and mechanism of therapeutic effects9
Critical update and discussion of the prevalence, nature, mechanisms of action, and treatment options in potentially serious coronary anomalies9
J wave syndromes: What's new?8
Disseminated Lyme disease and dilated cardiomyopathy: A systematic review8
Cardiac allograft vasculopathy after heart transplantation: Pathophysiology, detection approaches, prevention, and treatment management8
Sodium-glucose cotransporter type 2 inhibitors and cardiac arrhythmias8
Investigation of arterial claudication with transcutaneous oxygen pressure at exercise: Interests and limits8
The right ventricle in “Left-sided” cardiomyopathies: The dark side of the moon8
Contemporary management of acute pulmonary embolism8
Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again8
Circadian regulated control of myocardial ischemia-reperfusion injury8
Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models7
Clinical applicability of artificial intelligence for patients with an inherited heart disease: A scoping review7
Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations7
Contemporary approach to treating heart failure7
Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease management7
Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: A systematic review with Bayesian and frequentist meta-analysis7
Interatrial shunt devices for the treatment of heart failure7
Understanding the pathogenesis of coronary slow flow: Recent advances7
New approaches for treating atrial fibrillation: Focus on autonomic modulation7
New approach to managing infective endocarditis7
Clinical features of Danon disease and insights gained from LAMP-2 deficiency models7
Benefits of early rhythm control of atrial fibrillation7
The role of cardiac CT and MRI in the diagnosis and management of primary cardiac lymphoma: A comprehensive review7
Long-term cardiac surveillance and outcomes of COVID-19 patients6
Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis6
Postural orthostatic tachycardia syndrome: New concepts in pathophysiology and management6
Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions6
MicroRNA-mediated control of myocardial infarction in diabetes6
Transcatheter interventions for valvular heart diseases in liver cirrhosis patients6
Antihyperglycemic therapies and cardiovascular outcomes in patients with type 2 diabetes mellitus: State of the art and future directions6
Importance of clonal hematopoiesis in heart failure6
Update review on myocardial bridging: New insights6
Optical coherence tomography and coronary revascularization: from indication to procedural optimization6
SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure6
Respect versus resect approaches for mitral valve repair: A study-level meta-analysis6
Heart team 2.0: A decision tree for minimally invasive and hybrid myocardial revascularization6
One gene, two modes of inheritance, four diseases: A systematic review of the cardiac manifestation of pathogenic variants in JPH2-encoded junctophilin-26
0.08997106552124